NEWS
Ag Policy Blog
Chris Clayton DTN Ag Policy Editor
Wed May 15, 2013 05:14 PM CDT

The Christian faith teaches to provide for the poor, but Jesus was never faced with having to reduce the budget for popular legislation and try to get that bill passed by the House of Representatives.

Perhaps, rather than asking, "What would Jesus do?" the question becomes, "What would Caesar Augustus do?"

The point is raised because over the past couple of years as the House Agriculture Committee has gone down the path of seeking cuts to nutrition programs, the argument has led to a debate over the role of a Christian in Congress in deciding how to handle programs for ...

Quick View
  • Stay on Top of SDS The distinctive yellow patches of sudden death syndrome (SDS) are surfacing in soybean fields acr...
  • Cattle Market There may be a little less bull in this fall's calf market, but the fundamentals still spell oppo...
  • Precision Ag Potential Pending Precision agriculture proponents insist the industry can revolutionize agriculture, but first mor...
  • Cash Rent Reset - 1 With sub-$4 corn forecast for multiple years, growers need to make a preemptive strike on their 2...
  • Iowa Land Gets a Bounce Key Midwest land values are stuck in neutral or sliding below 2014 levels, recently released opin...
  • Canadian Dairy Conundrum Coping with Canada's dairy industry import tariffs and supply controls remains one of the stickin...
  • Senior Partners - 5 This fatherly financial advice is meant to prevent heartaches should the farm economy suffer anot...
  • Ask the Taxman by Andy Biebl CPA Andy Biebl answers readers' questions on depreciation recapture, defining a "true" lease and ...
  • Ask the Vet Does my calf have a hernia and is it repairable?
Related News Stories
Checkoff Programs Controversial
Washington Insider-- Friday
Rancher Asks Court: Stop EPA
Washington Insider-- Thursday
National Injunction Argued
Ozone Standard Questioned
Washington Insider
Washington Insider--Wednesday
California Drought Challenges
Activists Targeting Biotech